The role of miRNA in selected tumors development: Potential use in diagnostics
Postepy Higieny i Medycyny Doswiadczalnej, ISSN: 1732-2693, Vol: 75, Issue: 1, Page: 1-11
2021
- 7Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures7
- Readers7
Article Description
MicroRNAs (miRNAs) are small ribonucleic acid molecules that, although not translated, perform an important regulatory function in eukaryotic cells. Their physiological function is to maintain cell homeostasis. Impaired miRNA expression can cause the development of many diseases including cancer. MiRNA biological activity is based on inhibiting the formation of proteins, including oncogenic and anti-oncogenic proteins. Mutations at the coding sites for such miRNAs can lead to overproduction or reduction of the production of the above-mentioned proteins. The discovery of miRNAs and understanding their role in the cell opened new ways for diagnosing cancer. Therefore, changes in the level of relevant miRNAs in the bloodstream or other bodily fluids can be a diagnostic marker of disease. Oncological diagnostics could be based on examining the patient's miRNA profile and comparing it with previously developed profiles of miRNAs changes associated with the occurrence of a given type of cancer. Information on changes in miRNA profiles that are key to regulating gene expression associated with tumorigenic processes could contribute to the development of experimental therapies based on restoring the original level of miRNA in cells and thereby restoring normal regulation of gene expression. New methods of silencing and enabling miRNA expression may, in the future, result in effective therapeutic solutions.
Bibliographic Details
Walter de Gruyter GmbH
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know